FDA Moves to Ease Restrictions on Compounded Peptides

Washington, Friday, 16 October 2026.
The FDA proposed a policy to temporarily allow pharmacies to compound certain restricted peptides, opening access to a multi-billion-dollar market as commercial firms structure distribution strategies.